Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Modeling low-dose mortality and disease incubation period of inhalational anthrax in the rabbit.

Gutting BW, Marchette D, Sherwood R, Andrews GA, Director-Myska A, Channel SR, Wolfe D, Berger AE, Mackie RS, Watson BJ, Rukhin A.

J Theor Biol. 2013 Jul 21;329:20-31. doi: 10.1016/j.jtbi.2013.03.020. Epub 2013 Apr 6.

PMID:
23567649
2.

Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia.

Gutting BW, Nichols TL, Channel SR, Gearhart JM, Andrews GA, Berger AE, Mackie RS, Watson BJ, Taft SC, Overheim KA, Sherwood RL.

Front Cell Infect Microbiol. 2012 Jun 28;2:87. doi: 10.3389/fcimb.2012.00087. eCollection 2012.

3.

Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model.

Cote CK, Bozue J, Twenhafel N, Welkos SL.

J Med Microbiol. 2009 Jun;58(Pt 6):816-25. doi: 10.1099/jmm.0.008656-0.

PMID:
19429760
4.

Post-exposure therapy of inhalational anthrax in the common marmoset.

Nelson M, Stagg AJ, Stevens DJ, Brown MA, Pearce PC, Simpson AJ, Lever MS.

Int J Antimicrob Agents. 2011 Jul;38(1):60-4. doi: 10.1016/j.ijantimicag.2011.03.003. Epub 2011 May 6.

PMID:
21530184
5.

Deterministic models of inhalational anthrax in New Zealand white rabbits.

Gutting B.

Biosecur Bioterror. 2014 Jan-Feb;12(1):29-41. doi: 10.1089/bsp.2013.0067. Epub 2014 Feb 14.

6.

Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures in the rabbit model.

Barnewall RE, Comer JE, Miller BD, Gutting BW, Wolfe DN, Director-Myska AE, Nichols TL, Taft SC.

Front Cell Infect Microbiol. 2012 Jun 13;2:71. doi: 10.3389/fcimb.2012.00071. eCollection 2012.

7.

Modelling the incubation period of anthrax.

Brookmeyer R, Johnson E, Barry S.

Stat Med. 2005 Feb 28;24(4):531-42.

PMID:
15678407
8.

Modeling the incubation period of inhalational anthrax.

Wilkening DA.

Med Decis Making. 2008 Jul-Aug;28(4):593-605. doi: 10.1177/0272989X08315245. Epub 2008 Jun 12.

PMID:
18556642
9.

Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus).

Lever MS, Stagg AJ, Nelson M, Pearce P, Stevens DJ, Scott EA, Simpson AJ, Fulop MJ.

Int J Exp Pathol. 2008 Jun;89(3):171-9. doi: 10.1111/j.1365-2613.2008.00581.x.

10.

Inhalational anthrax.

Cuneo BM.

Respir Care Clin N Am. 2004 Mar;10(1):75-82. Review.

PMID:
15062228
11.

Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak.

Brookmeyer R, Johnson E, Bollinger R.

Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10129-32. Epub 2003 Jul 30.

12.

Pulmonary deposition of aerosolized Bacillus atrophaeus in a Swine model due to exposure from a simulated anthrax letter incident.

Duncan EJ, Kournikakis B, Ho J, Hill I.

Inhal Toxicol. 2009 Feb;21(2):141-52. doi: 10.1080/08958370802412629 .

PMID:
18923948
13.

An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.

Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.

Vaccine. 2006 May 1;24(18):3953-63. Epub 2006 Feb 28.

PMID:
16530302
14.

Addressing residual risk issues at anthrax cleanups: how clean is safe?

Canter DA.

J Toxicol Environ Health A. 2005 Jun 11-25;68(11-12):1017-32. Review.

PMID:
16020189
15.

Pathology of inhalational anthrax animal models.

Twenhafel NA.

Vet Pathol. 2010 Sep;47(5):819-30. doi: 10.1177/0300985810378112. Epub 2010 Jul 23. Review.

PMID:
20656900
16.

Key aspects of the molecular and cellular basis of inhalational anthrax.

Cote CK, Welkos SL, Bozue J.

Microbes Infect. 2011 Dec;13(14-15):1146-55. doi: 10.1016/j.micinf.2011.07.005. Epub 2011 Jul 21. Review.

PMID:
21816231
17.

The physiologic responses of Dutch belted rabbits infected with inhalational anthrax.

Lawrence WS, Hardcastle JM, Brining DL, Weaver LE, Ponce C, Whorton EB, Peterson JW.

Comp Med. 2009 Jun;59(3):257-65.

18.

Dose-Response Modeling for Inhalational Anthrax in Rabbits Following Single or Multiple Exposures.

Gutting BW, Rukhin A, Marchette D, Mackie RS, Thran B.

Risk Anal. 2016 Nov;36(11):2031-2038. doi: 10.1111/risa.12564. Epub 2016 Feb 17.

PMID:
26889937
19.

Bioterrorism. This time it was real: knowledge of anthrax put to the test.

Enserink M.

Science. 2001 Oct 19;294(5542):490-1. No abstract available.

PMID:
11641469
20.

Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.

Heine HS, Bassett J, Miller L, Bassett A, Ivins BE, Lehoux D, Arhin FF, Parr TR Jr, Moeck G.

Antimicrob Agents Chemother. 2008 Sep;52(9):3350-7. doi: 10.1128/AAC.00360-08. Epub 2008 Jul 7.

Supplemental Content

Support Center